Sökresultat - Mingfeng Han
- Visas 1 - 12 av 12 resultat
-
1
-
2
-
3
-
4
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China av Ruirui Wang, Min Pan, Xiumei Zhang, Mingfeng Han, Xiaoyun Fan, Fengde Zhao, Manli Miao, Jing Xu, Minglong Guan, Deng Xia, Xu Chen, Leilei Shen
Publicerad 2020Artigo -
5
-
6
Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference av Yafei Zhang, Changtai Wang, Mingfeng Han, Jun Ye, Yong Gao, Zhongping Liu, Tengfei He, Tuantuan Li, Mengyuan Xu, Lu-Ping Zhou, Guizhou Zou, Mengji Lu, Zhenhua Zhang
Publicerad 2020Artigo -
7
Differentially expressed immune response genes in COVID-19 patients based on disease severity av Shasha Li, Xiaoqiong Duan, Yujia Li, Ming Li, Yong Gao, Tuantuan Li, Shilin Li, Lin Tan, Tuo Shao, Andre J. Jeyarajan, Limin Chen, Mingfeng Han, Wenyu Lin, Xiuyong Li
Publicerad 2021Artigo -
8
Acute kidney injury at early stage as a negative prognostic indicator of patients with COVID-19: a hospital-based retrospective analysis av Xu Shen, Lin Fu, Jun Fei, Hui-Xian Xiang, Ying Xiang, Zhu-Xia Tan, Meng‐Die Li, Fangfang Liu, Ying Li, Mingfeng Han, Xiuyong Li, Dexin Yu, Hui Zhao, De‐Xiang Xu
Publicerad 2020Pré-impressão -
9
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial av Ke Hu, Wei‐jie Guan, Ying Bi, Wei Zhang, Lanjuan Li, Boli Zhang, Qingquan Liu, Yuanlin Song, Xingwang Li, Zhongping Duan, Qingshan Zheng, Zifeng Yang, Jingyi Liang, Mingfeng Han, Lianguo Ruan, Chaomin Wu, Yunting Zhang, Zhenhua Jia, Nanshan Zhong
Publicerad 2020Artigo -
10
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial av Wei Tang, Zhujun Cao, Mingfeng Han, Zhengyan Wang, Junwen Chen, Wenjin Sun, Yaojie Wu, Wei Xiao, Shengyong Liu, Erzhen Chen, Wei Chen, Xiongbiao Wang, Jiuyong Yang, Jun Lin, Qingxia Zhao, Youqin Yan, Zhibin Xie, Dan Li, Yaofeng Yang, Leshan Liu, Jieming Qu, Guang Ning, Guochao Shi, Qing Xie
Publicerad 2020Pré-impressão -
11
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial av Wei Tang, Zhujun Cao, Mingfeng Han, Zhengyan Wang, Junwen Chen, Wenjin Sun, Yaojie Wu, Wei Xiao, Shengyong Liu, Erzhen Chen, Wei Chen, Xiongbiao Wang, Jiuyong Yang, Jun Lin, Qingxia Zhao, Youqin Yan, Zhibin Xie, Dan Li, Yaofeng Yang, Leshan Liu, Jieming Qu, Guang Ning, Guochao Shi, Qing Xie
Publicerad 2020Artigo -
12
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial av Dongsheng Wang, Binqing Fu, Zhen Peng, Dongliang Yang, Mingfeng Han, Min Li, Yun Yang, Tianjun Yang, Liangye Sun, Wei Li, Wei Shi, Xin Yao, Yan Ma, Fei Xu, Xiaojing Wang, Jun Chen, Daqing Xia, Yubei Sun, Lin Dong, Jumei Wang, Xiaoyu Zhu, Min Zhang, Yonggang Zhou, Aijun Pan, Xiaowen Hu, Xiaodong Mei, Haiming Wei, Xiaoling Xu
Publicerad 2021Artigo
Sökverktyg:
Relaterade ämnen
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Medicine
Internal medicine
Adverse effect
Biology
Pathology
Gastroenterology
Randomized controlled trial
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology
Coronavirus
Cytokine
Environmental health
Epidemiology
Gene
Genetics
Hydroxychloroquine
Immunology
Interleukin 6
Population
Retrospective cohort study
Severity of illness
Tocilizumab
2019-20 coronavirus outbreak
Acute kidney injury
Adenocarcinoma
Alternative medicine
Anesthesia